Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021

Autor: Daniel S. Graciaa, Hans P. Verkerke, Jeannette Guarner, Ana Maria Moldoveanu, Narayanaiah Cheedarla, Connie M. Arthur, Cheryl L. Maier, Andrew Neish, Sara C. Auld, Angie Campbell, Neel R. Gandhi, John D. Roback, N. Sarita Shah
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Druh dokumentu: article
ISSN: 2732-494X
DOI: 10.1017/ash.2022.298
Popis: We describe severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG seroprevalence and antigenemia among patients at a medical center in January–March 2021 using residual clinical blood samples. The overall seroprevalences were 17% by infection and 16% by vaccination. Spent or residual samples are a feasible alternative for rapidly estimating seroprevalence or monitoring trends in infection and vaccination.
Databáze: Directory of Open Access Journals